IPP Bureau
Zydus receives final approval from the USFDA for Sildenafil for Oral Suspension
By IPP Bureau - October 01, 2022
Sildenafil for Oral Suspension had annual sales of USD 65 million in the United States according to IQVIA data (IQVIA MAT Aug 2022).
USFDA inspects Zydus Lifesciences Ahmedabad SEZ facility
By IPP Bureau - September 30, 2022
The company will address the observations within a stipulated timeline working with the regulators
Lupin receives US FDA approval for Mirabegron Extended-Release tablets
By IPP Bureau - September 30, 2022
Mirabegron Extended-Release Tablets, 25 mg and 50 mg, had estimated annual sales of US $2.4 billion in US
Lupin receives warning letter from US FDA
By IPP Bureau - September 30, 2022
The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility
CAPED Trust and AstraZeneca India launch ‘Ganga Godavari Cancer Screening Program’ in Mathura
By IPP Bureau - September 30, 2022
In the next six months, the program aims to screen 4,000 women from underprivileged communities in and around Mathura
Emmes acquires Clinical Edge
By IPP Bureau - September 30, 2022
The combination of Optym, Emmes' ophthalmology certification unit, and Clinical Edge will make the organization a leader in ophthalmic certification and training services
Lupin launches Sildenafil for Oral Suspension in US
By IPP Bureau - September 30, 2022
Sildenafil for Oral Suspension (RLD Revatio) had estimated annual sales of US $64 million in the US
Torrent Pharma to acquire Curatio Healthcare for Rs. 2,000 Cr
By IPP Bureau - September 28, 2022
The consideration includes Rs. 115 crore (on the date of signing) of cash and cash equivalents in the acquired business indicating an Enterprise Value of Rs. 1,885 crore
South Korea nextgen sequencing tests market to grow at 4% CAGR during 2022-2030: GlobalData
By IPP Bureau - September 28, 2022
There is also a growing interest in whole generation sequencing (WGS)
Cardiac Surgeons call for lifestyle and dietary changes on World Heart Day
By IPP Bureau - September 28, 2022
There are certain foods can influence blood pressure, triglycerides, cholesterol levels and inflammation, all of which are risk factors for heart disease.
NIHR addresses research in surgery in India
By IPP Bureau - September 28, 2022
The two-day meeting in the city was organized in collaboration with the University of Birmingham, Christian Medical College Ludhiana, and Birmingham Clinical Trials Unit
Zentalis promotes Kevin Bunker to Chief Scientific Officer
By IPP Bureau - September 28, 2022
Dr. Bunker will focus on leading Research and Development (R&D) in San Diego, advancing the preclinical pipeline and optimizing the Company’s Integrated Discovery Engine.
Julie Brown appointed as CFO of GSK
By IPP Bureau - September 28, 2022
Julie Brown is currently Chief Operating and Financial Officer, Burberry Group.
EDQM grants CEP certificate to Supriya Lifescience for Diphenhydramine Hydrochloride
By IPP Bureau - September 28, 2022
This will be an added advantage for Supriya Lifescience Limited in the European market.
Supriya Lifescience appoints Rajeev Kumar Jain as CEO
By IPP Bureau - September 28, 2022
He is a seasoned professional having worked in reputed corporates in API business with over 35+ years of experience covering manufacturing, general management, and business
